At a glance
Quantoom's vision
Biopsy-to-injection turnaround time
of current cost / patient
Deployable at or near point-of-care
Fast, low cost and decentralized
We power the paradigm shift: a fast, flexible, end-to-end workflow that turns a biopsy into a personalized RNA treatment.
While today's biopsy-to-treatment cycle runs several weeks (4 weeks), our ambition is to go one step further:
Obtaining a needle to needle cycle in less than a week at a fraction of today's cost, deployable at or near the point of care.
Because for a cancer patient, time, access and cost are the treatment.
Personalized cancer treatments
Quantoom is active on multiple R&D programs in this field.
To learn more, please contact us.
Manufactured for you, or produced in your facility
Hospitals, research centers and biotechs can start with Quantoom manufacturing, then take design and production in-house when they are ready — on the same N-Force process.
Manufacturing with Quantoom
Quantoom designs and manufactures personalized cancer RNA treatments for hospitals, oncology centers and biotechs.
Production at your site
A technology transfer gives you Quantoom's end-to-end workflow. You then design and manufacture at your facility, under your own control. Ncode, Ntensify® and Ncapsulate® stay in the process so every patient-specific batch follows the same path.
Quantoom collaborates with a US-based top cancer center
Personalized cancer therapeutics moves further when the right science meets the right clinic. The collaboration covers mRNA formulation technology — a research license and supply agreement for treatments designed around a single patient.
Quantoom Biosciences Signs Research License and Supply Agreement with Leading Global Cancer Center for mRNA Formulation Technology in Personalized Cancer Therapeutics
Read the announcement

